1. Home
  2. NTRB

NTRB

Nutriband Inc.

Logo Nutriband Inc.

Health Care

Industrial Specialties

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Founded: N/A Country:
United States
United States
Employees: N/A City: ORLANDO
Market Cap: 36.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 42.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.67 EPS Growth: N/A
52 Week Low/High: $1.53 - $5.93 Next Earning Date: 06-07-2024
Revenue: $2,088,236 Revenue Growth: 2.17%
Revenue Growth (this year): 59.4% Revenue Growth (next year): N/A

Share on Social Networks: